These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37621654)

  • 1. Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis.
    Collins KE; Wang X; Klymenko Y; Davis NB; Martinez MC; Zhang C; So K; Buechlein A; Rusch DB; Creighton CJ; Hawkins SM
    Front Endocrinol (Lausanne); 2023; 14():1162786. PubMed ID: 37621654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma.
    Shin HY; Yang W; Chay DB; Lee EJ; Chung JY; Kim HS; Kim JH
    Mol Oncol; 2021 Apr; 15(4):987-1004. PubMed ID: 33331115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA GAS5 inhibits the proliferation and invasion of ovarian clear cell carcinoma via the miR-31-5p/ARID1A axis.
    Zhang J; Yang ZM; Huang Y; Wang KN; Xie Y; Yang N
    Kaohsiung J Med Sci; 2021 Nov; 37(11):940-950. PubMed ID: 34414664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma.
    Yanaihara N; Noguchi Y; Saito M; Takenaka M; Takakura S; Yamada K; Okamoto A
    PLoS One; 2016; 11(9):e0162584. PubMed ID: 27612152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular changes in endometriosis-associated ovarian clear cell carcinoma.
    Worley MJ; Liu S; Hua Y; Kwok JS; Samuel A; Hou L; Shoni M; Lu S; Sandberg EM; Keryan A; Wu D; Ng SK; Kuo WP; Parra-Herran CE; Tsui SK; Welch W; Crum C; Berkowitz RS; Ng SW
    Eur J Cancer; 2015 Sep; 51(13):1831-42. PubMed ID: 26059197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
    Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
    Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
    Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential expression of miRNAs between ovarian endometrioma and endometriosis-associated ovarian cancer.
    Nakamura N; Terai Y; Nunode M; Kokunai K; Konishi H; Taga S; Nakamura M; Yoo M; Hayashi M; Yamashita Y; Ohmichi M
    J Ovarian Res; 2020 May; 13(1):51. PubMed ID: 32359364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct molecular pathways in ovarian endometrioid adenocarcinoma with concurrent endometriosis.
    Zhang C; Wang X; Anaya Y; Parodi L; Cheng L; Anderson ML; Hawkins SM
    Int J Cancer; 2018 Nov; 143(10):2505-2515. PubMed ID: 30152524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes.
    Tan TZ; Ye J; Yee CV; Lim D; Ngoi NYL; Tan DSP; Huang RY
    EBioMedicine; 2019 Dec; 50():203-210. PubMed ID: 31761620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic Steroid Hormones Regulated Cell Proliferation Through MicroRNA-34a-5p in Human Ovarian Endometrioma.
    Hsu CY; Hsieh TH; Tsai CF; Chen HS; Liang PI; Hsu YL; Tsai EM
    Biol Reprod; 2016 Mar; 94(3):60. PubMed ID: 26819477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing the progression of an endometrioma: Benign or malignant?
    Bastu E; Onder S; Demiral I; Ozsurmeli M; Keskin G; Takmaz O; Ozaltin S; Gorgen H; Gungor M; Yavuz E; Buyru F
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():79-84. PubMed ID: 30245441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
    Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation.
    Liu Y; Cao Y; Cai W; Wu L; Zhao P; Liu XG
    PeerJ; 2020; 8():e9100. PubMed ID: 32377460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatic analysis of dysregulated microRNA-mRNA co-expression network in ovarian endometriosis.
    Liu Y; Fan L; Jin L; Lu C; Li T; Zhang Z; Xie C; Li S; Zhang Y; Ren J; Lu D
    Acta Obstet Gynecol Scand; 2022 Oct; 101(10):1074-1084. PubMed ID: 35876135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma: A Two-Center Cohort Study and Meta-analysis.
    Kim HS; Kim MA; Lee M; Suh DH; Kim K; No JH; Chung HH; Kim YB; Song YS
    Ann Surg Oncol; 2015 Aug; 22(8):2738-45. PubMed ID: 25680339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-503, a microRNA epigenetically repressed in endometriosis, induces apoptosis and cell-cycle arrest and inhibits cell proliferation, angiogenesis, and contractility of human ovarian endometriotic stromal cells.
    Hirakawa T; Nasu K; Abe W; Aoyagi Y; Okamoto M; Kai K; Takebayashi K; Narahara H
    Hum Reprod; 2016 Nov; 31(11):2587-2597. PubMed ID: 27619772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
    Yamaguchi K; Mandai M; Oura T; Matsumura N; Hamanishi J; Baba T; Matsui S; Murphy SK; Konishi I
    Oncogene; 2010 Mar; 29(12):1741-52. PubMed ID: 20062075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.
    Kim SI; Lee JW; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Seo JS
    Gynecol Oncol; 2018 Feb; 148(2):375-382. PubMed ID: 29233531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma.
    Mikami M; Tanabe K; Matsuo K; Miyazaki Y; Miyazawa M; Hayashi M; Asai S; Ikeda M; Shida M; Hirasawa T; Kojima N; Sho R; Iijima S
    Gynecol Oncol; 2015 Dec; 139(3):520-8. PubMed ID: 26477941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.